About Aptamer Sciences
Aptamer Sciences is a company based in Pohang-si (South Korea) founded in 2011.. The company has 55 employees as of December 31, 2024. Aptamer Sciences operates in a competitive market with competitors including Aptamer Group, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
- Headquarter Pohang-si, South Korea
- Employees 55 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aptamer Sciences, Inc.
-
Annual Revenue
$732.24 K (USD)345.26as on Dec 31, 2024
-
Net Profit
$-5.9 M (USD)36.02as on Dec 31, 2024
-
EBITDA
$-4.18 M (USD)47.04as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
55
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aptamer Sciences
Aptamer Sciences is a publicly listed company on the KRX with ticker symbol 291650 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Aptamer Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Aptamer Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aptamer Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aptamer Sciences Comparisons
Competitors of Aptamer Sciences
Aptamer Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Group, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
|
|
| domain | founded_year | HQ Location |
Services for custom aptamer development
|
|
| domain | founded_year | HQ Location |
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
|
|
| domain | founded_year | HQ Location |
Aptamers are developed and provided via SELEX platform technology.
|
|
| domain | founded_year | HQ Location |
Aptamer-based biotechnological applications are developed for diverse uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aptamer Sciences
Frequently Asked Questions about Aptamer Sciences
When was Aptamer Sciences founded?
Aptamer Sciences was founded in 2011.
Where is Aptamer Sciences located?
Aptamer Sciences is headquartered in Pohang-si, South Korea. It is registered at Pohang-si, North Gyeongsang Province, South Korea.
How many employees does Aptamer Sciences have?
As of Dec 31, 2024, the latest employee count at Aptamer Sciences is 55.
What is the annual revenue of Aptamer Sciences?
Annual revenue of Aptamer Sciences is $732.24K as on Dec 31, 2024.
What does Aptamer Sciences do?
Aptamer Sciences was founded in 2011 as a biotechnology firm specializing in aptamer-based solutions. Technologies for protein analysis are commercialized through a proprietary platform, supported by an association with POSTECH. Broad access to SELEX intellectual property is held among four companies, enabling research and development of aptamers. Emphasis is placed on aptamers that target cellular proteins for diagnostic and analytical applications.
Who are the top competitors of Aptamer Sciences?
Aptamer Sciences's top competitors include Aptamer Group, Base Pair Biotechnologies and Apta Biotech.
Is Aptamer Sciences publicly traded?
Yes, Aptamer Sciences is publicly traded on KRX under the ticker symbol 291650.
What is Aptamer Sciences's ticker symbol?
The ticker symbol of Aptamer Sciences is 291650 on KRX.